| 注册
首页|期刊导航|中国免疫学杂志|41种细胞因子和生长因子与血清阴性的类风湿关节炎的因果关系:一项双样本孟德尔随机化研究

41种细胞因子和生长因子与血清阴性的类风湿关节炎的因果关系:一项双样本孟德尔随机化研究

凌益 任妮娜 王秋燚 姚血明 马武开

中国免疫学杂志2025,Vol.41Issue(9):2081-2086,6.
中国免疫学杂志2025,Vol.41Issue(9):2081-2086,6.DOI:10.3969/j.issn.1000-484X.2025.09.006

41种细胞因子和生长因子与血清阴性的类风湿关节炎的因果关系:一项双样本孟德尔随机化研究

Association of 41 circulating interleukins and growth factors with risk of seronegative rheumatoid arthritis:A Mendelian randomization study

凌益 1任妮娜 1王秋燚 1姚血明 1马武开1

作者信息

  • 1. 贵州中医药大学第二临床医学院,贵阳 550000
  • 折叠

摘要

Abstract

Objective:To explore the association of serum levels of 41 serum cytokines and growth factors with the risk of sero-negative rheumatoid arthritis(SNRA)by Mendelian randomization.Methods:Genetic instruments for 41 circulating cytokines and growth factors were determined from a genome-wide association study(GWAS)of 8 293 European participants.Summary statistics for the SNRA were obtained from the Finnish database,including 3 877 SNRA cases and 285 035 controls of European ancestry.All of the inverse variance weighted(IVW),weighted median method(WM)and MR-Egger regression were used for MR analysis,while the IVW method was considered as the main analysis.The sensitivity analysis included a heterogeneity test,horizontal pleiotropic test,and leave-one method test to determine the reliability of the MR results.Results:In the IVW method,TNF-α[OR=1.470,95%CI(1.1331~1.910),P=0.004],IP-10[OR=0.794,95%CI(0.660~0.955),P=0.015]and IL-2rα[OR=0.049,95%CI(0.856~0.999),P=0.049].Sensitivity analysis showed no heterogeneity and horizontal pleiotropy.Conclusion:TNF-α,IP-10 and IL-2rα are causally associated to SNRA.TNF-α increases the risk of SNRA,while IP-10 and IL-2rα reduce the risk of SNRA.

关键词

血清细胞因子/血清阴性的类风湿关节炎/孟德尔随机化/因果关系

Key words

Serum cytokines/Seronegative rheumatoid arthritis/Mendelian randomization/Causality

分类

医药卫生

引用本文复制引用

凌益,任妮娜,王秋燚,姚血明,马武开..41种细胞因子和生长因子与血清阴性的类风湿关节炎的因果关系:一项双样本孟德尔随机化研究[J].中国免疫学杂志,2025,41(9):2081-2086,6.

基金项目

国家自然科学基金(82274678,82160869,82405366) (82274678,82160869,82405366)

贵州省科技计划项目[黔科合平台人才(2020)2202,黔科合支撑(2021)一般006,黔科合基础-ZK(2023)一般412,黔科合成果LC(2025)一般021] (2020)

贵科合学术新苗项目(2023-36) (2023-36)

贵州中医药大学国家与省级科技创新人才团队培育项目[贵中医TD合字(2022)004号] (2022)

贵州中医药大学第二附属医院"三航"人才培养工程(SHRC-KY2024018). (SHRC-KY2024018)

中国免疫学杂志

OA北大核心

1000-484X

访问量1
|
下载量0
段落导航相关论文